{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:46:05Z","timestamp":1776897965624,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"DOI":"10.7759\/cureus.47759","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:53:06Z","timestamp":1698371586000},"source":"Crossref","is-referenced-by-count":12,"title":["Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities"],"prefix":"10.7759","author":[{"given":"Akshad M","family":"Wadbudhe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivangi C","family":"Tidke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00023","article-title":"Clinical, immunological and molecular findings in 57 patients with severe combined immunodeficiency (SCID) from India","volume":"10","author":"Aluri J","year":"2019","unstructured":"Aluri J, Desai M, Gupta M, et al.. Clinical, immunological and molecular findings in 57 patients with severe combined immunodeficiency (SCID) from India. Front Immunol. 2019, 10:23. 10.3389\/fimmu.2019.00023","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-315484","article-title":"Fifteen-minute consultation: recognising primary immune deficiencies in children","volume":"104","author":"Wekell P","year":"2019","unstructured":"Wekell P, Hertting O, Holmgren D, Fasth A. Fifteen-minute consultation: recognising primary immune deficiencies in children. Arch Dis Child Educ Pract Ed. 2019, 104:235-43. 10.1136\/archdischild-2018-315484","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.013","article-title":"Primary immunodeficiencies: 2009 update","volume":"124","author":"Notarangelo LD","year":"2009","unstructured":"Notarangelo LD, Fischer A, Geha RS, et al.. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009, 124:1161-78. 10.1016\/j.jaci.2009.10.013","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","article-title":"Severe combined immunodeficiency","author":"Justiz Vaillant AA","year":"2023","unstructured":"Justiz Vaillant AA, Mohseni M. Severe combined immunodeficiency. StatPearls. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref5","unstructured":"Types of SCID. Accessed. August 20, 2023: https:\/\/scidcompass.org\/types-scid."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2015.07.002","article-title":"Severe combined immunodeficiency disorders","volume":"35","author":"Chinn IK","year":"2015","unstructured":"Chinn IK, Shearer WT. Severe combined immunodeficiency disorders. Immunol Allergy Clin North Am. 2015, 35:671-94. 10.1016\/j.iac.2015.07.002","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00426","article-title":"Failing to make ends meet: the broad clinical spectrum of DNA ligase IV deficiency. Case series and review of the literature","volume":"6","author":"Staines Boone AT","year":"2018","unstructured":"Staines Boone AT, Chinn IK, Alaez-Vers\u00f3n C, et al.. Failing to make ends meet: the broad clinical spectrum of DNA ligase IV deficiency. Case series and review of the literature. Front Pediatr. 2018, 6:426. 10.3389\/fped.2018.00426","journal-title":"Front Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2300","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017","volume":"143","author":"Amatuni GS","year":"2019","unstructured":"Amatuni GS, Currier RJ, Church JA, et al.. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California, 2010-2017. Pediatrics. 2019, 143:10.1542\/peds.2018-2300","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.10.012","article-title":"Development of population-based newborn screening for severe combined immunodeficiency","volume":"115","author":"Chan K","year":"2005","unstructured":"Chan K, Puck JM. Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol. 2005, 115:391-8. 10.1016\/j.jaci.2004.10.012","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan A","year":"2014","unstructured":"Kwan A, Abraham RS, Currier R, et al.. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014, 312:729-38. 10.1001\/jama.2014.9132","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.01.032","article-title":"Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles","volume":"129","author":"Puck JM","year":"2012","unstructured":"Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol. 2012, 129:607-16. 10.1016\/j.jaci.2012.01.032","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.07.007","article-title":"A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)","volume":"104","author":"Chan K","year":"2011","unstructured":"Chan K, Davis J, Pai SY, Bonilla FA, Puck JM, Apkon M. A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID). Mol Genet Metab. 2011, 104:383-9. 10.1016\/j.ymgme.2011.07.007","journal-title":"Mol Genet Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80951-5","article-title":"Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients","volume":"123","author":"Stephan JL","year":"1993","unstructured":"Stephan JL, Vlekova V, Le Deist F, et al.. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993, 123:564-72. 10.1016\/s0022-3476(05)80951-5","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2015.01.026","article-title":"Positive family history, infection, low absolute lymphocyte count (ALC) and absent thymic shadow: diagnostic clues for all molecular forms of severe combined immunodeficiency (SCID)","volume":"3","author":"McWilliams LM","year":"2015","unstructured":"McWilliams LM, Dell Railey M, Buckley RH. Positive family history, infection, low absolute lymphocyte count (ALC) and absent thymic shadow: diagnostic clues for all molecular forms of severe combined immunodeficiency (SCID). J Allergy Clin Immunol Pract. 2015, 3:585-91. 10.1016\/j.jaip.2015.01.026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.29262\/ram.v62i2.66","article-title":"[Discriminant analysis to predict the clinical diagnosis of primary immunodeficiencies: a preliminary report]","volume":"62","author":"Murata C","year":"2015","unstructured":"Murata C, Ram\u00edrez AB, Ram\u00edrez G, Cruz A, Morales JL, Lugo-Reyes SO. [Discriminant analysis to predict the clinical diagnosis of primary immunodeficiencies: a preliminary report]. Rev Alerg Mex. 2015, 62:125-33.","journal-title":"Rev Alerg Mex"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0003-x","article-title":"ICON: the early diagnosis of congenital immunodeficiencies","volume":"34","author":"Routes J","year":"2014","unstructured":"Routes J, Abinun M, Al-Herz W, et al.. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol. 2014, 34:398-424. 10.1007\/s10875-014-0003-x","journal-title":"J Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1542\/pir.36-11-489","article-title":"Autoimmunity and immunodeficiency","volume":"36","author":"Dosanjh A","year":"2015","unstructured":"Dosanjh A. Autoimmunity and immunodeficiency. Pediatr Rev. 2015, 36:489-94; quiz 495. 10.1542\/pir.36-11-489","journal-title":"Pediatr Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.03.005","article-title":"Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): not only infections, but high risk of autoimmune complications","volume":"191","author":"De Rose DU","year":"2018","unstructured":"De Rose DU, Giliani S, Notarangelo LD, et al.. Long term outcome of eight patients with type 1 Leukocyte Adhesion Deficiency (LAD-1): not only infections, but high risk of autoimmune complications. Clin Immunol. 2018, 191:75-80. 10.1016\/j.clim.2018.03.005","journal-title":"Clin Immunol"},{"key":"ref19","unstructured":"Severe combined immunodeficiency and combined immunodeficiency. Accessed. August 20, 2023: https:\/\/primaryimmune.org\/disease\/severe-combined-immunodeficiency-and-combined-immunodeficiency."},{"key":"ref20","article-title":"Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients","volume":"91","author":"Haddad E","year":"1998","unstructured":"Haddad E, Landais P, Friedrich W, et al.. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood. 1998, 91:3646-53.","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai SY","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM, et al.. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 2014, 371:434-46. 10.1056\/NEJMoa1401177","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99","volume":"361","author":"Antoine C","year":"2003","unstructured":"Antoine C, M\u00fcller S, Cant A, et al.. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet Lond Engl. 2003, 361:553-560. 10.1016\/s0140-6736(03)12513-5","journal-title":"Lancet Lond Engl"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery AR","year":"2010","unstructured":"Gennery AR, Slatter MA, Grandin L, et al.. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?. J Allergy Clin Immunol. 2010, 126:602-10.e1-11. 10.1016\/j.jaci.2010.06.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9917-y","article-title":"The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901","volume":"33","author":"Dvorak CC","year":"2013","unstructured":"Dvorak CC, Cowan MJ, Logan BR, et al.. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J Clin Immunol. 2013, 33:1156-64. 10.1007\/s10875-013-9917-y","journal-title":"J Clin Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall J","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, et al.. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood. 2017, 130:2718-27. 10.1182\/blood-2017-05-781849","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-11-748616","article-title":"Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report","volume":"129","author":"Abd Hamid IJ","year":"2017","unstructured":"Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report. Blood. 2017, 129:2198-201. 10.1182\/blood-2016-11-748616","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo M","year":"2000","unstructured":"Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al.. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000, 288:669-72. 10.1126\/science.288.5466.669","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti A","year":"2009","unstructured":"Aiuti A, Cattaneo F, Galimberti S, et al.. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009, 360:447-58. 10.1056\/NEJMoa0805817","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300393","article-title":"Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency","volume":"16","author":"Thornhill SI","year":"2008","unstructured":"Thornhill SI, Schambach A, Howe SJ, et al.. Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther. 2008, 16:590-8. 10.1038\/sj.mt.6300393","journal-title":"Mol Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.265","article-title":"Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency","volume":"22","author":"Carbonaro DA","year":"2014","unstructured":"Carbonaro DA, Zhang L, Jin X, et al.. Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther. 2014, 22:607-22. 10.1038\/mt.2013.265","journal-title":"Mol Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2477","article-title":"Knockout mice created by TALEN-mediated gene targeting","volume":"31","author":"Sung YH","year":"2013","unstructured":"Sung YH, Baek IJ, Kim DH, et al.. Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol. 2013, 31:23-4. 10.1038\/nbt.2477","journal-title":"Nat Biotechnol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nature13420","article-title":"Targeted genome editing in human repopulating haematopoietic stem cells","volume":"510","author":"Genovese P","year":"2014","unstructured":"Genovese P, Schiroli G, Escobar G, et al.. Targeted genome editing in human repopulating haematopoietic stem cells. Nature. 2014, 510:235-40. 10.1038\/nature13420","journal-title":"Nature"},{"key":"ref33","unstructured":"Enzyme Replacement Therapy. Accessed. August 20, 2023: https:\/\/scidcompass.org\/enzyme-replacement-therapy."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7013.1","article-title":"Recent advances in treatment of severe primary immunodeficiencies","volume":"4","author":"Gennery A","year":"2015","unstructured":"Gennery A. Recent advances in treatment of severe primary immunodeficiencies. F1000Res. 2015, 4:10.12688\/f1000research.7013.1","journal-title":"F1000Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley RH","year":"1999","unstructured":"Buckley RH, Schiff SE, Schiff RI, et al.. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999, 340:508-16. 10.1056\/NEJM199902183400703","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V81.8.2021.2021","article-title":"Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation","volume":"81","author":"Dror Y","year":"1993","unstructured":"Dror Y, Gallagher R, Wara DW, Colombe BW, Merino A, Benkerrou M, Cowan MJ. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood. 1993, 81:2021-30.","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-029090","article-title":"Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype","volume":"109","author":"Cavazzana-Calvo M","year":"2007","unstructured":"Cavazzana-Calvo M, Carlier F, Le Deist F, et al.. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood. 2007, 109:4575-81. 10.1182\/blood-2006-07-029090","journal-title":"Blood"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter MA","year":"2011","unstructured":"Slatter MA, Rao K, Amrolia P, et al.. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood. 2011, 117:4367-75. 10.1182\/blood-2010-10-312082","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12309","article-title":"A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency","volume":"18","author":"Dvorak CC","year":"2014","unstructured":"Dvorak CC, Horn BN, Puck JM, Czechowicz A, Shizuru JA, Ko RM, Cowan MJ. A trial of plerixafor adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency. Pediatr Transplant. 2014, 18:602-8. 10.1111\/petr.12309","journal-title":"Pediatr Transplant"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-550327","article-title":"In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice","volume":"124","author":"Derderian SC","year":"2014","unstructured":"Derderian SC, Togarrati PP, King C, et al.. In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice. Blood. 2014, 124:973-80. 10.1182\/blood-2014-02-550327","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184143-severe-combined-immunodeficiency-scid-and-its-new-treatment-modalities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:50Z","timestamp":1707509270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184143-severe-combined-immunodeficiency-scid-and-its-new-treatment-modalities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.47759","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}